Methylation and silencing of miRNA-124 by EVI1 and self-renewal exhaustion of hematopoietic stem cells in murine myelodysplastic syndrome.
By expressing EVI1 in murine bone marrow (BM), we previously described a myelodysplastic syndrome (MDS) model characterized by pancytopenia, dysmegakaryopoiesis, dyserythropoiesis, and BM failure. The mice invariably died 11-14 months after BM transplantation (BMT). Here, we show that a double point mutant EVI1-(1+6Mut), unable to bind Gata1, abrogates the onset of MDS in the mouse and re-establishes normal megakaryopoiesis, erythropoiesis, BM function, and peripheral blood profiles. These normal features were maintained in the reconstituted mice until the study was ended at 21 months after BMT. We also report that EVI1 deregulates several genes that control cell division and cell self-renewal. In striking contrast, these genes are normalized in the presence of the EVI1 mutant. Moreover, EVI1, but not the EVI1 mutant, seemingly deregulates these cellular processes by altering miRNA expression. In particular, the silencing of miRNA-124 by DNA methylation is associated with EVI1 expression, but not that of the EVI1 mutant, and appears to play a key role in the up-regulation of cell division in murine BM cells and in the hematopoietic cell line 32Dcl3. The results presented here demonstrate that EVI1 induces MDS in the mouse through two major pathways, both of which require the interaction of EVI1 with other factors: one, results from EVI1-Gata1 interaction, which deregulates erythropoiesis and leads to fatal anemia, whereas the other occurs by interaction of EVI1 with unidentified factors causing perturbation of the cell cycle and self-renewal, as a consequence of silencing miRNA-124 by EVI1 and, ultimately, ensues in BM failure.
Dickstein
Jerome
J
Department of Pathology, University of Chicago, Chicago, IL 60637, USA. Jerome.Dickstein@uchospitals.edu
Senyuk
Vitalyi
V
Premanand
Kavitha
K
Laricchia-Robbio
Leopoldo
L
Xu
Peng
P
Cattaneo
Francesca
F
Fazzina
Raffaella
R
Nucifora
Giuseppina
G
D000818:Animals; D016026:Bone Marrow Transplantation; D002454:Cell Differentiation; D049109:Cell Proliferation; D002478:Cells, Cultured; D018899:CpG Islands; D004261:DNA Replication; D004268:DNA-Binding Proteins / Q000235:genetics / Q000378:metabolism*; D005786:Gene Expression Regulation; D006412:Hematopoietic Stem Cells / Q000166:cytology*; D000074008:MDS1 and EVI1 Complex Locus Protein; D008745:Methylation; D051379:Mice; D035683:MicroRNAs / Q000235:genetics*; D008969:Molecular Sequence Data; D009154:Mutation; D009190:Myelodysplastic Syndromes / Q000235:genetics* / Q000378:metabolism* / Q000473:pathology; D011401:Promoter Regions, Genetic; D011519:Proto-Oncogenes / Q000235:genetics; D034622:RNA Interference; D014157:Transcription Factors / Q000235:genetics / Q000378:metabolism*
D004268:DNA-Binding Proteins; D000074008:MDS1 and EVI1 Complex Locus Protein; C499305:Mecom protein, mouse; D035683:MicroRNAs; C540079:Mirn124 microRNA, mouse; D014157:Transcription Factors
Cell Growth Differ. 1999 Sep;10(9):601-10
10511310
Science. 2005 May 20;308(5725):1171-4
15905401
Mol Cell Biol. 1992 Jan;12(1):183-9
1370341
Nat Med. 2010 Feb;16(2):198-204
20098431
EMBO J. 2004 Oct 13;23(20):4116-25
15385956
N Engl J Med. 1999 May 27;340(21):1649-60
10341278
Nat Genet. 2008 Jul;40(7):915-20
18536716
Carcinogenesis. 2010 May;31(5):766-76
19843643
Mech Dev. 1997 Jul;65(1-2):55-70
9256345
Blood. 2008 May 15;111(10):4841-51
18467609
Mol Cell Biol. 2006 Oct;26(20):7658-66
16954386
Cancer Cell. 2007 Oct;12(4):295-7
17936553
J Clin Invest. 2004 Sep;114(5):713-9
15343390
Ann N Y Acad Sci. 2005 Jun;1044:109-16
15958703
Nat Med. 2006 Apr;12(4):401-9
16582916
Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):11857-62
18697930
BMC Med. 2008 Jun 24;6:14
18577219
Oncogene. 2002 May 13;21(21):3368-76
12032775
Blood. 2005 Oct 1;106(7):2530-3
15933056
Nature. 2003 May 15;423(6937):255-60
12714970
Blood Cells Mol Dis. 2008 Mar-Apr;40(2):141-7
17913523
Nature. 1994 Sep 15;371(6494):221-6
8078582